The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The company showcased three core programs developed through this platform
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
The centre established by Nucleome Informatics will take up the sequencing of 5,000 Covid genomes and 500 human genomes in the coming months
Subscribe To Our Newsletter & Stay Updated
